BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9695934)

  • 1. Food deprivation decreases mRNA and activity of the rat dopamine transporter.
    Patterson TA; Brot MD; Zavosh A; Schenk JO; Szot P; Figlewicz DP
    Neuroendocrinology; 1998 Jul; 68(1):11-20. PubMed ID: 9695934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.
    Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ
    J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
    Rothblat DS; Schroeder JA; Schneider JS
    J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study.
    Figlewicz DP; Brot MD; McCall AL; Szot P
    Brain Res; 1996 Oct; 736(1-2):54-60. PubMed ID: 8930308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium depletion and aldosterone decrease dopamine transporter activity in nucleus accumbens but not striatum.
    Roitman MF; Patterson TA; Sakai RR; Bernstein IL; Figlewicz DP
    Am J Physiol; 1999 May; 276(5):R1339-45. PubMed ID: 10233025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
    Régo JC; Syringas M; Leblond B; Costentin J; Bonnet JJ
    Br J Pharmacol; 1999 Sep; 128(1):51-60. PubMed ID: 10498834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma membrane expression of striatal dopamine transporter in aging.
    Salvatore MF; Apparsundaram S; Gerhardt GA
    Neurobiol Aging; 2003 Dec; 24(8):1147-54. PubMed ID: 14643386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area.
    Adelbrecht C; Agid Y; Raisman-Vozari R
    Brain Res Mol Brain Res; 1996 Dec; 43(1-2):291-300. PubMed ID: 9037545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine upregulates the dopamine transporter in fetal rhesus monkey brain.
    Fang Y; Ronnekleiv OK
    J Neurosci; 1999 Oct; 19(20):8966-78. PubMed ID: 10516315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra.
    Figlewicz DP; Szot P; Chavez M; Woods SC; Veith RC
    Brain Res; 1994 May; 644(2):331-4. PubMed ID: 8050044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporters participate in the physiological regulation of prolactin.
    Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME
    Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat.
    Letchworth SR; Daunais JB; Hedgecock AA; Porrino LJ
    Brain Res; 1997 Mar; 750(1-2):214-22. PubMed ID: 9098547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
    Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
    J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions.
    Hoffman AF; Gerhardt GA
    J Neurochem; 1998 Jan; 70(1):179-89. PubMed ID: 9422361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.
    Houlihan WJ; Kelly L; Pankuch J; Koletar J; Brand L; Janowsky A; Kopajtic TA
    J Med Chem; 2002 Sep; 45(19):4097-109. PubMed ID: 12213053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain.
    Bossé R; Rivest R; Di Paolo T
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):343-6. PubMed ID: 9191114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.
    Blanchard V; Raisman-Vozari R; Vyas S; Michel PP; Javoy-Agid F; Uhl G; Agid Y
    Brain Res Mol Brain Res; 1994 Mar; 22(1-4):29-38. PubMed ID: 7912404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.
    Kimmel HL; Carroll FI; Kuhar MJ
    Neuropharmacology; 2000 Feb; 39(4):578-85. PubMed ID: 10728879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices.
    Hoffman AF; Lupica CR; Gerhardt GA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):487-96. PubMed ID: 9808671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in dopamine transporter and c-Fos expression in the nucleus accumbens of alcohol-tolerant rats.
    Yoshimoto K; Ueda S; Nishi M; Yang Y; Matsushita H; Takeuchi Y; Kato B; Kawai Y; Noritake K; Kaneda S; Sorimachi Y; Yasuhara M
    Alcohol Clin Exp Res; 2000 Mar; 24(3):361-5. PubMed ID: 10776677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.